Читаем Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний полностью

Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

Бастиан Блоэм , Майкл Окун , Рэй Дорси , Тодд Шерер

33. Roser M. Life expectancy. Our World in Data. https://ourworldindata. org/life-expectancy. Accessed March 31, 2019.

34. Там же.

35. Paid notice: Deaths: Hoehn, Professor Margaret “Peggy,” M.D. New York Times. July 24, 2005: 1001032.

36. International programs: International Data Base. US Census Bureau. www.census.gov/data-tools/demo/idb/informationGateway.php. Updated: September 2018. Accessed November 19, 2018; Population ages 65 and above, total. World Bank. https://data.worldbank.org/indicator/ SP.POP.65UP.To. Accessed November 19, 2018.

37. Levy G. The relationship of Parkinson disease with aging. Archives of Neurology. 2007;64(9):1242–1246.

38. Savica R, Rocca WA, Ahlskog JE. When does Parkinson disease start? Archives of Neurology. 2010;67(7):798–801.

39. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. American Journal of Epidemiology. 2003;157(11):1015–1022. www.ncbi. nlm.nih.gov/pubmed/12777365.

40. Scutti S. Drug overdoses, suicides cause drop in 2017 US life expectancy; CDC director calls it a “wakeup call.” CNN. December 17, 2018. www.cnn. com/2018/11/29/health/life-expectancy-2017-cdc/index.html. Accessed February 15, 2019; Naik G. Global life expectancy increases by about six years: study in Lancet says rise is results of dramatic health-care advances. Wall Street Journal. December 18, 2014; Murray CJL, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life

years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet. 2015;386(10009):2145–2191.

41. Wanneveich M, Moisan F, Jacqmin-Gadda H, Elbaz A, Joly P. Projections of prevalence, lifetime risk, and life expectancy of Parkinson’s disease (2010–2030) in France. Movement Disorders. 2018;33(9):1449–1455.

42. Proctor RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tobacco Control. 2012;21(2):87–91.

43. Там же.

44. Там же.; Lung cancer. Wikipedia. https://en.wikipedia.org/wiki/Lung_ cancer. Accessed February 15, 2019.

45. Keating C. Smoking Kills: The Revolutionary Life of Richard Doll. Oxford: Signal Books; 2009.

46. Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. BMJ. 1956;2(5001):1071–1081.

47. Proctor RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tobacco Control. 2012;21(2):87–91.

48. Flanders WD, Lally CA, Zhu B-P, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption. Cancer Research. 2003;63(19):6556–6562.

49. Pesch B, Kendzia B, Gustavsson P, et al. Cigarette smoking and lung cancer – relative risk estimates for the major histological types from a pooled analysis of case-control studies. International Journal of Cancer. 2012;131(5):1210–1219.

50. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939–953; Li X, Li W, Liu G, Shen X, Tang Y. Association between cigarette smoking and Parkinson’s disease: a meta-analysis. Archives of Gerontology and Geriatrics. 2015;61(3):510–516.

51. Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Translational Neurodegeneration. 2017;6:18; Maggio R, Riva M, Vaglini F, et al. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. Journal of Neurochemistry. 1998;71(6):2439–2446; Allam MF, Serrano del Castillo A, Fernandez-Crehuet Navajas R. Smoking and Parkinson’s disease: explanatory hypothesis. International Journal of Neuroscience. 2002; 112(7):851–854; Miksys S, Tyndale RF. Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease. Journal of Neural Transmission, Supplement. 2006(70):177–180.

52. Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLOS ONE. 2013;8(3):e59260; Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking smoking, coffee, urate, and Parkinson’s disease – a role for gut microbiota? Journal of Parkinsons Disease. 2015;5(2):255–262.

Перейти на страницу: